Godlike Productions - Reply to Thread

Users Online Now: 1,679 (Who's On?)	Visitors Today: 602,941
Pageviews Today: 1,013,586	Threads Today: 368	Posts Today: 6,759
11:42 AM

REPLY TO THREAD

Subject Pfizer has a new alopecia drug! Will's slap was an ad!

User Name

Font color: Font:

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.

Original Message Pfizer has been developing Ritlecitinib, a drug for aloepecia.

[link to www.fiercebiotech.com (secure)]

"Pfizer's alopecia therapy has been linked to a reduction in hair loss in early topline clinical data, setting the stage for a scrap with Eli Lilly and Incyte in the title fight for a potential blockbuster opportunity.

Ritlecitinib has met its primary endpoint in a phase 2b/3 clinical trial of patients with alopecia areata, Pfizer reported Wednesday. The update on the JAK3/TEC inhibitor comes months after Eli Lilly and Incyte reported late-phase success in alopecia.

There are currently no FDA-approved treatments for alopecia, an autoimmune disease characterized by hair loss, but multiple drugs could come to market in the indication over the coming years. Pfizer’s ritlecitinib joined Lilly and Incyte’s Olumiant on the list of drugs to hit the primary endpoint in pivotal alopecia trials on Wednesday—and Concert Pharmaceuticals is following closely behind."

More pure PR at source.

Pictures (click to insert)





\| Next Page >>